Market Value425,474,000
Total Holdings50
File Date2021-05-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
HLXA / Helix Acquisition Corp - Class A
KURA / Kura Oncology, Inc.
QQQ / Invesco QQQ Trust, Series 1 Put
MRTX / Mirati Therapeutics, Inc.
FGEN / FibroGen, Inc.
IMUX / Immunic, Inc.
CLDX / Celldex Therapeutics, Inc. Put
XENE / Xenon Pharmaceuticals Inc.
ARVN / Arvinas, Inc.
US2103731061 / Constellation Pharmaceuticals Inc
CBIO / Crescent Biopharma, Inc.
NVAX / Novavax, Inc.
KDMN / Kadmon Holdings Inc
IOVA / Iovance Biotherapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
SRRA / Sierra Oncology Inc
TRIL / Trillium Therapeutics Inc
VTGN / Vistagen Therapeutics, Inc.
CMRX / Chimerix, Inc.
IWM / iShares Trust - iShares Russell 2000 ETF
FREQ / Frequency Therapeutics Inc Put
859319303 / Sterling Financial Corp
FATE / Fate Therapeutics, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
CASI / CASI Pharmaceuticals, Inc.
EPIX / ESSA Pharma Inc.
CLDX / Celldex Therapeutics, Inc.
MRSN / Mersana Therapeutics, Inc.
ALDX / Aldeyra Therapeutics, Inc.
VRDN / Viridian Therapeutics, Inc.
CRIS / Curis, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
ACRS / Aclaris Therapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.
APVO / Aptevo Therapeutics Inc.
SAGE / Sage Therapeutics, Inc.
ISEE / IVERIC bio Inc
ARKG / ARK ETF Trust - ARK Genomic Revolution ETF Put
CTIC / CTI BioPharma Corp
OTIC / Otonomy Inc
DTIL / Precision BioSciences, Inc.
NUVB / Nuvation Bio Inc.
BIIB / Biogen Inc.
TGTX / TG Therapeutics, Inc.
IMVT / Immunovant, Inc.
COGT / Cogent Biosciences, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc.